These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15775675)

  • 1. Altered expression of TGF-beta receptors in hepatocellular carcinoma--effects of a constitutively active TGF-beta type I receptor mutant.
    Musch A; Rabe C; Paik MD; Berna MJ; Schmitz V; Hoffmann P; Nischalke HD; Sauerbruch T; Caselmann WH
    Digestion; 2005; 71(2):78-91. PubMed ID: 15775675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
    Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
    Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
    Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
    Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
    J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
    Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
    Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
    Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
    Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients.
    Kim IY; Ahn HJ; Lang S; Oefelein MG; Oyasu R; Kozlowski JM; Lee C
    Clin Cancer Res; 1998 Jul; 4(7):1625-30. PubMed ID: 9676836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ; Ward-van Oostwaard D; Wianny F; Savatier P; Zwijsen A; Mummery C
    Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.